Unichem Laboratories Board of Directors

Get the latest insights into the leadership at Unichem Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Prakash A Mody Chairman
Mr. Pabitrakumar Bhattacharyya Managing Director
Mr. Pranay Godha Non Exe.Non Ind.Director
Ms. Priti Puri Independent Director
Mr. Anand Kusre Independent Director
Mr. Arun Todarwal Independent Director

Unichem Laboratories Share price

UNICHEMLAB

502

0.80 (0.16%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

508.70

Today's Low

500.00

52 Week Low

483.00

52 Week High

937.95

The current prices are delayed, login to your account for live prices

Unichem Laboratories FAQs

The board at Unichem Laboratories consists of experienced professionals, including Dr. Prakash A Mody , Mr. Pabitrakumar Bhattacharyya , and others, overseeing the company’s strategic and corporate governance.

Directors at Unichem Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Prakash A Mody is the current chairman at Unichem Laboratories.

Executive directors at Unichem Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Unichem Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Unichem Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.